Pharsight

Climara Pro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5676968 BAYER HLTHCARE Transdermal therapeutic systems with crystallization inhibitors
Oct, 2014

(9 years ago)

Climara Pro is owned by Bayer Hlthcare.

Climara Pro contains Estradiol; Levonorgestrel.

Climara Pro has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Climara Pro are:

  • US5676968

Climara Pro was authorised for market use on 21 November, 2003.

Climara Pro is available in film, extended release;transdermal dosage forms.

The generics of Climara Pro are possible to be released after 14 October, 2014.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 21 November, 2003

Treatment: NA

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

More Information on Dosage

CLIMARA PRO family patents

Family Patents